- Correction
- Open access
- Published:
Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
Environmental Health and Preventive Medicine volume 23, Article number: 30 (2018)
The Original Article was published on 24 October 2017
Correction
Following publication of the original article [1], the authors reported a correction in the units in the methods section under “Subjects”
Originally, the sentence was stated as:
(ii) exhibited no evidence of prostate cancer as determined by blood test (PSA < 4 mg/dL)
The correct sentence is:
(ii) exhibited no evidence of prostate cancer as determined by blood test (PSA < 4 ng/ml)
Reference
Koda M, et al. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan. Environ Health Prev Med. 2017;22:72. https://doi.org/10.1186/s12199-017-0681-0.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Koda, M., Iwasaki, M., Yamano, Y. et al. Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan. Environ Health Prev Med 23, 30 (2018). https://doi.org/10.1186/s12199-018-0718-z
Published:
DOI: https://doi.org/10.1186/s12199-018-0718-z